Table 1. Clinical Demographic Profile Among CHD and Controls Groups.

A retrospective collection of plasma samples from patients with diagnosed coronary heart disease (CHD) and healthy controls were included in the study. The two groups were matched based on male/female ratio and total plasma cholesterol. Inclusion criteria comprised patients who self-reported white/European race/ethnicity and non-smoker status, confirmed by referencing medical records to ensure non-use of lipid-lowering medications. Comparative analysis of total control to total CHD revealed that CHD patients were significantly older and had higher BMIs and elevated plasma Preβ HDL concentrations, while otherwise plasma lipids levels showed no significant differences between the groups. Significance between Control and CHD groups was determined using a t-test with p <0.05.

	Control (N=67)		Coronary Heart Disease (N=41)		Significance
Male/Female	M: N = 29 (43%) F: N = 38 (57%)		M: N =19 (46%) F: N = 22 (54%)		No
	Average (S.D.)	Range	Average (S.D.)	Range
Age	35.3 (11.3)	18–58	50.7 (7.9)	29–61	Yes
Body Mass Index (kg/m2)	24.9 (4.3)	18–42	26.9 (5.5)	18.3–47.4	Yes
Total Cholesterol (mg/dL)	184.1 (36.3)	68–285	193.5 (57.8)	102–335	No
Triglycerides (mg/dL)	85.8 (39)	33–276	98.0 (48.1)	33–270	No
LDL-Cholesterol (mg/dL)	102.8 (34.3)	17–189	116.4 (52.9)	21–243	No
HDL-Cholesterol (mg/dL)	64.0 (17.8)	25–101	59.6 (22.3)	29–107	No
hsCRP (mg/L)	2.8 (2.7)	0.01–18.0	2.4 (3)	0.01–13.0	No
Preβ HDL (mg/dL apoA1)	10.2 (4.0)	3.7–20.3	13.5 (5.4)	3.7–25.6	Yes